NDC 60505-7075
Buprenorphene
Buprenorphene
Buprenorphene is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Buprenorphine.
Product ID | 60505-7075_47eb2ff6-1cee-2ea0-558c-99d51c900b13 |
NDC | 60505-7075 |
Product Type | Human Prescription Drug |
Proprietary Name | Buprenorphene |
Generic Name | Buprenorphene |
Dosage Form | Patch, Extended Release |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2021-09-29 |
Marketing Category | ANDA / |
Application Number | ANDA210272 |
Labeler Name | Apotex Corp. |
Substance Name | BUPRENORPHINE |
Active Ingredient Strength | 5 mg/h |
Pharm Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC] |
DEA Schedule | CIII |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |